Cost-effective management of low-risk papillary thyroid carcinoma.
OBJECTIVE
To compare the 20-year cost-effectiveness of initial hemithyroidectomy vs total thyroidectomy in the management of small papillary thyroid cancer in the low-risk patient.


METHODS
Pooled data from the published literature were used to determine key statistics for decision analysis such as rates of recurrence, rates of complications for all interventions undertaken, and rates of death. The 2005 costs were obtained from the US Department of Health and Human Services, as well as from Medicare reimbursement schedules. Future costs were discounted at 6%.


METHODS
Decision analysis study.


METHODS
Data from the published literature.


METHODS
A state-transition (Markov) decision model was constructed based on the most recent American Thyroid Association recommendations. A cost-effectiveness analysis was performed using fixed probability estimates and Monte Carlo microsimulation, with effectiveness defined as cause-specific mortality or recurrence-free survival. After identifying initial results, sensitivity and threshold analyses were performed to assess the strength of the recommendations.


RESULTS
Initial probability estimates were determined from a review of 940 abstracts and 31 relevant studies examining outcomes in patients with low-risk thyroid cancer undergoing thyroidectomy or neck dissection. During 20 years, cost estimates (including initial surgery, follow-up, and treatment of recurrence) were between $13,896.81 and $14,241.24 for total thyroidectomy and between $15,037.58 and $15,063.75 for hemithyroidectomy. Cause-specific mortality was similar for both treatment strategies, but recurrence-free survival was higher in the total thyroidectomy group. Sensitivity and threshold analyses demonstrated that these results were sensitive to rates of recurrence and cost of follow-up but remained robust when compared with willingness to pay.


CONCLUSIONS
Total thyroidectomy dominates over hemithyroidectomy as initial treatment for low-risk papillary thyroid cancer. However, in sensitivity analyses, these results varied by institution because of heterogeneity in long-term treatment outcomes. With changing protocols of management, it is possible that hemithyroidectomy will emerge as being more cost-effective. Long-term prospective trials are necessary to validate our findings.
Shrime
Mark G
MG
Department of Otolaryngology, Head and Neck Surgery, University of Toronto Health Network, Toronto, ON, Canada. shrime@alumni.princeton.edu
Goldstein
David P
DP
Seaberg
Raewyn M
RM
Sawka
Anna M
AM
Rotstein
Lorne
L
Freeman
Jeremy L
JL
Gullane
Patrick J
PJ
D002291:Carcinoma, Papillary / Q000191:economics / Q000601:surgery*; D003362:Cost-Benefit Analysis; D003657:Decision Making; D017048:Health Care Costs; D006801:Humans; D018570:Risk Assessment; D013964:Thyroid Neoplasms / Q000191:economics / Q000601:surgery*; D013965:Thyroidectomy / Q000191:economics* / Q000379:methods; D014481:United States